Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research (Q91430070)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

title

Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

main subject

Staphylococcus aureus

1 reference

methicillin-resistant Staphylococcus aureus

inferred from title

1 reference

Nicholas A Turner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Batu K Sharma-Kuinkel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Stacey A Maskarinec

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Emily M Eichenberger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Pratik P Shah

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Manuela Carugati

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Thomas L Holland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Vance G Fowler

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

publication date

1 April 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Microbiology

22 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

page(s)

203-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

High-density livestock operations, crop field application of manure, and risk of community-associated methicillin-resistant Staphylococcus aureus infection in Pennsylvania

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Decline of meticillin-resistant Staphylococcus aureus in Oxfordshire hospitals is strain-specific and preceded infection-control intensification

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Impact of strain typing methods on assessment of relationship between paired nares and wound isolates of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Persistent Environmental Contamination with USA300 Methicillin-Resistant Staphylococcus aureus and Other Pathogenic Strain Types in Households with S. aureus Skin Infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Intrahost Evolution of Methicillin-Resistant Staphylococcus aureus USA300 Among Individuals With Reoccurring Skin and Soft-Tissue Infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A comparison of the efficacy and safety of intravenous followed by oral delafloxacin with vancomycin plus aztreonam for the treatment of acute bacterial skin and skin structure infections: a phase 3, multinational, double-blind, randomized study.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Predictors of mortality in Staphylococcus aureus Bacteremia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Staphylococcus aureus: superbug, super genome?

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Architecture of a Species: Phylogenomics of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Next-Generation Sequence Analysis Reveals Transfer of Methicillin Resistance to a Methicillin-Susceptible Staphylococcus aureus Strain That Subsequently Caused a Methicillin-Resistant Staphylococcus aureus Outbreak: a Descriptive Study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Mobile genetic elements of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Frequency of disinfectant resistance genes and genetic linkage with beta-lactamase transposon Tn552 among clinical staphylococci

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Transferable vancomycin resistance in a community-associated MRSA lineage

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Panton-Valentine leukocidin is not the primary determinant of outcome for Staphylococcus aureus skin infections: evaluation from the CANVAS studies

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Staphylococcus aureus genomics and the impact of horizontal gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Evolution of mobile genetic element composition in an epidemic methicillin-resistant Staphylococcus aureus: temporal changes correlated with frequent loss and gain events

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Epidemiology of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Predominance of methicillin-resistant Staphylococcus aureus among pathogens causing skin and soft tissue infections in a large urban jail: risk factors and recurrence rates

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission?

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Trends in Methicillin-Resistant Staphylococcus aureus Hospitalizations in the United States, 2010-2014.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Health care-associated invasive MRSA infections, 2005-2008.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Changing Susceptibility of Staphylococcus aureus in a US Pediatric Population

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Genomic and Epidemiological Evidence for Community Origins of Hospital-Onset Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Systematic Surveillance Detects Multiple Silent Introductions and Household Transmission of Methicillin-Resistant Staphylococcus aureus USA300 in the East of England

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Demography and Intercontinental Spread of the USA300 Community-Acquired Methicillin-Resistant Staphylococcus aureus Lineage

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

The incidence of Staphylococcus aureus ST8-USA300 among French pediatric inpatients is rising.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Parallel Epidemics of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Infection in North and South America

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Emergence, spread, and characterization of phage variants of epidemic methicillin-resistant Staphylococcus aureus 16 in England and Wales

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Identification and characterization of phage variants of a strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-15).

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Shift in dominant hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) clones over time

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Spread of methicillin-resistant Staphylococcus aureus between the community and the hospitals in Asian countries: an ANSORP study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Latin-America: A Prospective Cohort Multicenter Study in Nine Countries

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Population-based epidemiology of Staphylococcus aureus bloodstream infection: clonal complex 30 genotype is associated with mortality

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular epidemiology and characteristic of virulence gene of community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus isolates in Sun Yat-sen Memorial hospital, Guangzhou, Southern China

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Characterization of community acquired Staphylococcus aureus associated with skin and soft tissue infection in Beijing: high prevalence of PVL+ ST398.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Bengal Bay clone ST772-MRSA-V outbreak: conserved clone causes investigation challenges.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

High-density livestock production and molecularly characterized MRSA infections in Pennsylvania

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Methicillin-resistant Staphylococcus aureus ST398 in humans and animals, Central Europe

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Staphylococcus aureus host specificity: comparative genomics of human versus animal isolates by multi-strain microarray

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Newly identified risk factors for MRSA carriage in The Netherlands

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Prevalence and predictors of nasal and extranasal staphylococcal colonization in patients presenting to the emergency department

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Colonization With Methicillin-resistant Staphylococcus aureus and Risk for Infection Among Asymptomatic Athletes: A Systematic Review and Metaanalysis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Duration of Colonization and Determinants of Earlier Clearance of Colonization With Methicillin-Resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Transmission of methicillin-resistant Staphylococcus aureus to household contacts

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Reversion of methicillin-resistant Staphylococcus aureus skin infections to methicillin-susceptible isolates

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Nasal swab screening for methicillin-resistant Staphylococcus aureus--how well does it perform? A cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Comparison of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay, BD GeneOhm MRSA assay, and culture for detection of nasal and cutaneous groin colonization by MRSA

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

High proportion of wrongly identified methicillin-resistant Staphylococcus aureus carriers by use of a rapid commercial PCR assay due to presence of staphylococcal cassette chromosome element lacking the mecA gene

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Nasal screening for MRSA: different swabs--different results!

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus colonization of healthy military personnel by traditional culture, PCR, and mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Sensitivities of nasal and rectal swabs for detection of methicillin-resistant Staphylococcus aureus colonization in an active surveillance program

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Throat and rectal swabs may have an important role in MRSA screening of critically ill patients.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Epidemiology and clinical relevance of Staphylococcus aureus intestinal carriage: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Methicillin-Resistant Staphylococcus aureus Colonization at Different Body Sites: a Prospective, Quantitative Analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Carriage rates of methicillin-resistant Staphylococcus aureus (MRSA) depend on anatomic location, the number of sites cultured, culture methods, and the distribution of clonotypes.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Anatomic sites of colonization with community-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

5 years of experience implementing a methicillin-resistant Staphylococcus aureus search and destroy policy at the largest university medical center in the Netherlands

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Veterans Affairs Initiative to Prevent Methicillin-ResistantStaphylococcus aureusInfections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Preoperative Staphylococcus Aureus Screening and Targeted Decolonization in Cardiac Surgery

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Impact of preoperative screening for meticillin-resistant Staphylococcus aureus by real-time polymerase chain reaction in patients undergoing cardiac surgery

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Targeted versus universal decolonization to prevent ICU infection

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Effect of daily chlorhexidine bathing on hospital-acquired infection

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Eradication of MRSA throat carriage - a randomized trial comparing topical treatment with rifampicin-based systemic therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Use of a Simple Criteria Set for Guiding Echocardiography in Nosocomial Staphylococcus aureus Bacteremia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Are vancomycin trough concentrations adequate for optimal dosing?

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Combination of Vancomycin and β-Lactam Therapy for Methicillin-ResistantStaphylococcus aureusBacteremia: A Pilot Multicenter Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Early surgery versus conventional treatment for infective endocarditis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Intrapulmonary pharmacokinetics of linezolid

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Clinical failures of appropriately-treated methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Daptomycin compared to vancomycin for the treatment of osteomyelitis: a single-center, retrospective cohort study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Daptomycin therapy for osteomyelitis: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Effectiveness and tolerability of prolonged linezolid treatment for chronic osteomyelitis: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Optimal Duration of Antibiotic Therapy in Patients With Hematogenous Vertebral Osteomyelitis at Low Risk and High Risk of Recurrence

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Prosthetic-joint infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A Large Multicenter Study of Methicillin–Susceptible and Methicillin–Resistant Staphylococcus aureus Prosthetic Joint Infections Managed With Implant Retention

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Early prosthetic joint infections treated with debridement and implant retention: 38 primary hip arthroplasties prospectively recorded and followed for median 4 years

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A Phase 3, Randomized, double-blind, multicenter study to EValuate the safety and efficacy of intravenous Iclaprim versus Vancomycin for the trEatment of acute bacterial skin and skin structure infections suspected or confirmed to be due to Gram-pos

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positiv

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Single-dose oritavancin in the treatment of acute bacterial skin infections.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Once-weekly dalbavancin versus daily conventional therapy for skin infection

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Status of vaccine research and development of vaccines for Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Artemis: sequence visualization and annotation

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular characterization of Staphylococcus aureus isolates from various healthcare institutions in Nairobi, Kenya: a cross sectional study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

National surveillance of methicillin-resistant Staphylococcus aureus in China highlights a still-evolving epidemiology with 15 novel emerging multilocus sequence types.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Prevalence of Major Methicillin-Resistant Staphylococcus aureus Clones in Korea Between 2001 and 2008.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Molecular epidemiology and antibiotic resistance of methicillin-resistant Staphylococcus aureus circulating in the Russian Federation.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A 12-year survey of methicillin-resistant Staphylococcus aureus infections in Greece: ST80-IV epidemic?

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

The dissemination of ST80-SCCmec-IV community-associated methicillin resistant Staphylococcus aureus clone in Kuwait hospitals

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Comparing pulsed-field gel electrophoresis with multilocus sequence typing, spa typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for panton-valentine leukocidin, arcA, and opp3 in methicillin-resistant Staphylococcus aureus is

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Continued Emergence of USA300 Methicillin-Resistant Staphylococcus aureus in the United States: Results from a Nationwide Surveillance Study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Potential Influence of Staphylococcus aureus Clonal Complex 30 Genotype and Transcriptome on Hematogenous Infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Whole genome sequencing of meticillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Pulse Field Gel Electrophoresis

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Poor value of pulsed-field gel electrophoresis to investigate long-term scale epidemiology of methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

spa Typing and Multilocus Sequence Typing Show Comparable Performance in a Macroepidemiologic Study of Staphylococcus aureus in the United States

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Evaluation of multiple-locus variable number of tandem repeats analysis for typing livestock-associated methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Comparison of an automated repetitive sequence-based PCR microbial typing system to pulsed-field gel electrophoresis for analysis of outbreaks of methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Application of whole-genome sequencing for bacterial strain typing in molecular epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Identification of a new repetitive element in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

STAR gene restriction profile analysis in epidemiological typing of methicillin-resistant Staphylococcus aureus: description of the new method and comparison with other polymerase chain reaction (PCR)-based methods.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infect

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Safety and efficacy of intravenous tigecycline in subjects with secondary bacteremia: pooled results from 8 phase III clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs

1 reference

https://api.crossref.org/works/10.1038%2FS41579-018-0147-4

7 January 2021

10.1038/S41579-018-0147-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

PubMed publication ID

30737488

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30737488%20AND%20SRC:MED&resulttype=core&format=json